Yorktown Management & Research Company’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
-2,100
Closed -$219K 407
2017
Q4
$219K Hold
2,100
0.06% 358
2017
Q3
$306K Hold
2,100
0.08% 244
2017
Q2
$273K Hold
2,100
0.09% 193
2017
Q1
$261K Hold
2,100
0.07% 235
2016
Q4
$243K Hold
2,100
0.06% 273
2016
Q3
$220K Hold
2,100
0.05% 237
2016
Q2
$207K Hold
2,100
0.05% 273
2016
Q1
$210K Hold
2,100
0.04% 321
2015
Q4
$251K Hold
2,100
0.04% 313
2015
Q3
$227K Hold
2,100
0.04% 375
2015
Q2
$243K Hold
2,100
0.04% 372
2015
Q1
$242K Sell
2,100
-900
-30% -$108K 0.04% 362
2014
Q4
$336K Hold
3,000
0.07% 122
2014
Q3
$284K Hold
3,000
0.05% 194
2014
Q2
$258K Hold
3,000
0.05% 299
2014
Q1
$209K Hold
3,000
0.04% 418
2013
Q4
$253K Hold
3,000
0.05% 290
2013
Q3
$231K Buy
+3,000
New +$210K 0.05% 278

Other funds holding CELG

Yorktown Management & Research Company's CELG Position: Q1 2018 in Review

Yorktown Management & Research Company sold out of Celgene Corp (CELG) in Q1 2018, closing a stake of 2,100 shares — an estimated $219K sold.

Yorktown Management & Research Company first reported a position in CELG in Q3 2013 and held it in 18 quarters. The position peaked at $336K in Q4 2014. 1,397 funds tracked by Wall St. Rank hold CELG as of Q1 2018.

  • Yorktown Management & Research Company reported no remaining Celgene Corp position as of Q1 2018 after selling out during the quarter.
  • Yorktown Management & Research Company sold 2,100 Celgene Corp shares in Q1 2018, an estimated $219K.
  • Yorktown Management & Research Company first reported a position in Celgene Corp in Q3 2013 and held it in 18 quarters.
  • Yorktown Management & Research Company's Celgene Corp position peaked at $336K in Q4 2014.
  • 1,397 funds tracked by Wall St. Rank held Celgene Corp as of Q1 2018.

Based on Yorktown Management & Research Company's 13F filing for Q1 2018, filed 11 May 2018.